Product Features Easy Shorten window period in Antigen detection Flexible Saliva sample, Nasal/Throat swabs sample, VTM Simple Visual result interpreted, no instrument required Rapid Result interpreted in 15 minutes
Diagnostic Kit for IgM/IgG 2 in 1 Antibody to 2019-nCoV (Colloidal Gold) Test principle This diagnostic kit adopts the principle of colloidal gold immunochromatographic test strip to make qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. Purpose This diagnostic kit is used for making qualitative test for 2019-nCoV IgM/IgG antibody in human serum, human plasma and whole blood samples. It acts as an early-stage aided diagnostic kit for clinical patients infecting 2019-nCoV, yet it is not the only standard for clinical diagnose. Sample requirements This kit is suitable for human serum (EDTA anticoagulant, heparin anticoagulant, trisodium citrate dihydrate anticoagulant 1:9), human plasma and whole blood samples.
Purpose This test kit is used for making qualitative test for COVID-19 antigen in human nose swab and throat swab samples. It acts as an early-stage aided diagnostic kit for clinical patients infecting COVID-19, yet it does not stand for the basis for confirming COVID-19. Sample requirements When using sterile swab for collecting samples, polyester sponge swab with PP bar is recommended when collecting nose swab and throat swab. When collecting nose swab, the swab will be gently inserted into the nose palatine and stay for a moment, and then gradually rotate it until it is taken out. When collecting throat swab, the swab will be completely inserted into the throat from the mouth, then inspectors will wipe pharyngeal tonsil on both sides and posterior wall of pharynx with appropriate strength, and finally take the swab out. During this process, please avoid touching the tongue. After collecting the samples, please make processing with viral transport medium or sample diluent provided in the test kit as soon as possible, and complete test within five minutes. Test principle This test kit adopts the principle of high-specificity antigen-antibody reaction and colloidal gold labelling and immunochromatographic test strip techniques. The reagent contains COVID-19-NP antigen monoclonal antibody pre-fixed in film test area and COVID-19-NP antigen monoclonal antibody-colloidal go
The KAiRA 2019-nCoV PCR Detection Kit is a one step RT-PCR reagent system, based on real-time PCR technology, for the qualitative detection and differentiation of lineage B-beta Coronavirus and severe acute respiratory syndrome coronavirus 2 specific RNA. The test kit has FDA and CE Approval and comes in packs of 100 tests. In combination with Dr PCR the test results for PCR Testing can be given in under an hour and are compatible for use for international travel requirements. Unit - Kit (1 kit contains 100 tests) Unit Price - $900 per kit
hrough market research and government trading department internal documents, we have complied a covid-19 related products suppliers contract info. The data consists of product introduction (including description and certification) and main markets they export. Supplier�¢??s name and contact person phone number. All the contract person are the one who directly responsible for international selling, and the phone number is her/his direct mobile phone. 100% accurate and updated at the end of March 2020 The data consists of 6 categories 1. Diagnostic reagent supplier (eg. Covid-19 test kit etc.) 2. Medical equipment (like ventilators etc.) supplier 3. Chinese patent medicine supplier 4. AI-aid diagnostic system supplier 5. Temperature measuring device supplier (eg. Thermometer etc.) 6. Disinfection equipment (eg irradiation system and disinfection gel, hand wash etc.) 7. Protective clothing Each categories price: USD 100 Full package of seven categories: USD: 600
Coronavirus Ag Rapid Test Cassette (Swab) have been placed on the European Market, based on the following performance characteristics (which are also included in the IFU included in each test kit) Coronavirus Ag Rapid Test Cassette (Swab) Method Coronavirus Ag Rapid Test Cassette Total Results Relative Sensitivity: 86.7% Relative Specificity: 100% Accuracy: 96.3% Coronavirus Ag Rapid Test Cassette (Swab) The CE mark has been applied as the products fit the definition of an in vitro diagnostic medical device as defined in the IVD Directive and are classified as a general IVD products as they are not included in List A or List B, and they are not intended to be used by lay users. Please note that this
Covid Ab IgG/IgM Ab Whole blood test device Sensitivity: 86.94% Specificity: 99.31% Accuracy: 93.36%
Disposable face masks, covid antigen tests, pulse oximeter.
The FactView Vitamin D Rapid Test Device is a diagnostic assay used for the qualitative detection of Vitamin D levels in blood samples. Here's more information about this type of diagnostic test: Purpose: The test is used for the rapid detection of Vitamin D deficiency or insufficiency. Vitamin D is essential for bone health, immune function, and various other physiological processes in the body. Principle: The FactView Vitamin D Rapid Test Device is typically an immunochromatographic assay that detects the presence of Vitamin D in a patient's blood sample. The test device contains specific antibodies or receptors that bind to Vitamin D molecules, leading to the formation of visible test lines. Components: The test kit usually includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific reagents for capturing Vitamin D molecules. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within a few minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of Vitamin D in the blood sample. A visible line in the control region indicates that the test is valid. Additional lines in the test region(s) indicate positive results for Vitamin D. Sensitivity and Specificity: The FactView Vitamin D Rapid Test Device demonstrates sensitivity and specificity for detecting Vitamin D levels within a certain range. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: The rapid detection of Vitamin D levels provides valuable information for assessing Vitamin D status, identifying deficiency or insufficiency, and guiding patient management decisions. Vitamin D deficiency is associated with various health problems, including bone disorders, immune dysfunction, and increased risk of certain diseases. Limitations: While rapid diagnostic tests are useful for Vitamin D screening, they have limitations compared to more accurate laboratory methods such as liquid chromatography-mass spectrometry (LC-MS). Factors such as test sensitivity, specificity, and the influence of interfering substances can affect test performance. Overall, the FactView Vitamin D Rapid Test Device is a convenient tool for assessing Vitamin D levels, allowing for timely intervention and management of Vitamin D-related health conditions. However, results should be interpreted carefully in conjunction with clinical evaluation and other laboratory tests.
"FactView Malaria Rapid PF/PV" likely refers to a diagnostic test for the rapid detection of Plasmodium falciparum (PF) and Plasmodium vivax (PV), two species of malaria parasites. Here's more information about this type of diagnostic test: Purpose: The FactView Malaria Rapid PF/PV test is used for the rapid detection of malaria infection caused by the Plasmodium falciparum and Plasmodium vivax parasites. Malaria is a serious infectious disease transmitted by the bite of infected Anopheles mosquitoes. Principle: The test is based on immunochromatographic principles, where specific antibodies are used to detect the presence of malaria antigens in a patient's blood sample. The presence of the PfHRP2 antigen indicates P. falciparum infection, while the presence of the pLDH antigen indicates P. vivax infection. Components: The FactView Malaria Rapid PF/PV test typically includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antibodies for detecting malaria antigens. Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes. Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of malaria antigens. A visible line in the control region indicates that the test is valid. Additional lines in the test regions indicate positive results for P. falciparum and/or P. vivax antigens. Sensitivity and Specificity: The FactView Malaria Rapid PF/PV test demonstrates high sensitivity and specificity for detecting malaria infections caused by P. falciparum and P. vivax parasites. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings. Utility: Rapid diagnostic tests like the FactView Malaria Rapid PF/PV provide a quick and convenient method for diagnosing malaria infections in resource-limited settings, where access to laboratory facilities and microscopy may be limited. Limitations: While rapid diagnostic tests are valuable tools for malaria diagnosis, they have limitations compared to more sensitive methods such as microscopy or molecular testing. Factors such as test storage conditions, operator technique, and the stage of infection can influence test performance.
CoVirion-CV19-2 SARS-CoV-2 OneStep RT-PCR kit is a probe-based Real Time PCR test designed for the qualitative detection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019. It is used to detect N-gene and S-gene in viral RNA.
Co-virion Rapid Antigen Test is an immunochromatographic test designed to qualitatively detect SARS-CoV- 2 antigen in nasopharyngeal geal swab specimens. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections. Co-virion Rapid Antigen Test is an immunochromatographic test designed to detect the nucleocapsid protein of SARS-CoV-2 in nasopharyngeal swabs (NP). The test strip contains colloidal-gold conjugated particles with monoclonal antibodies against the nu- cleo- capsid protein of SARS-CoV-2. The capture antibodies for nucleocapsid protein of SARS-CoV-2 are coated on the nitrocellulose membrane. When the sample is applied to the sample window (S well), the conjugates dried in the reagent pad are dissolved and migrate along with the sample. If SARS-CoV-2 is present in the sample, a complex formed between the anti-SARS-CoV-2 conjugate and the virus will be captured by the specific an- ti-SARS-CoV-2 monoclonal antibodies coated on the test line region (T), which develops a red line in T region. Presence of T line indicates a positive result. There is also an internal control line to check the accuracy of the test performance. The control line is coated with goat anti-Rabbit IgG antibody which binds to the gold labeled antibody. Failure to form C line confirms the incorrect procedural technique.
Cov-inu RT-PCR kit is a probe based Real Time PCR test designed for the qualitative de- tection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019 and A + B Group Inuenza virus (orthomyxovirus). It is used to detect S- M2 ve NS1 genes in viral RNA. Description of the Kit Cov-inu RT PCR Kit is a multiplex PCR kit that is used for the simultaneous detection of COVID-19 agent SARS-COV-2 and Inuenza A and Inuenza B viruses from the same sample. Coronaviruses are a large family of viruses that cause infections in humans and other mammals (such as camels, cats, dogs, and bats). The SARS-CoV-2 virus is a new coronavirus that was identified by the World Health Organization (WHO) (1) on February 11, 2020. Inuenza is caused by three types of immunological RNA viruses (A, B and C) in the Orthomyxoviridae family. Seasonal inuenza is typically caused by three main hem- agglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2). It is important that public health laboratories around the world conduct detailed surveillance to monitor the spread and impact of the pandemic H1N1 2009 virus, as well as predict future changes in virulence (4). Therefore, methods for rapid diagnosis, case detection and follow-up of this new pathogen in the human population are necessary to develop appropriate management strategies to reduce morbidity and mortality. The test works with single-stage real time reverse transcriptase polymerase chain reaction (On- eStep RT-PCR) with serum, lower respiratory tract samples (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract samples (e.g. nasopharyngeal uids, nasal swab) from individuals who demonstrate clinical criteria set for COVID-19 by WHO (2) and CDC (Center for Disease Control and Prevention) (3). This kit is an In-vitro diagnostic kit using specific primers designed for qualitative detection of genomic RNAs of SARS-CoV-2, Inuenza A and Inuenza B virus.
Kit Rapid Test, Hotgen, Clungene, Hightop, Newgene
Flowflex antigen kits
Bacterial Vaginosis Rapid Test Kit core Chromogenic Ingredient IBX-4041 IBX-4041 Testing vessel BV Blue active ingredient BVBlue active ingredient BVBlue substrates BV Blue substrates Chromogenic substrate IBX-4041 chromogenic substrate of sialidase enzyme Detection reagent for bacterial vaginosis (sialidase two-step method) Shenzhen BST Science & Technology Co., Ltd sells and exports chromogenic substrate of sialidase enzyme IBX-4041. Specification: Appearance: Light yellow solid powder Purity: 95% min Application: Two-step chromogenic substrates of neuraminidase (sialidase) BVBLUE Test Kit Component 1)BVBLUE Developer Solution: Water and Sodium hydroxide 2) BVBLUE Testing Vessel: Water, Potassium acetate, IBX-4041 (chromogenic substrate compound). IBX-4041 is the key ingredient of BVBLUE test kit, BVBLUE test is a rapid sialidase test for bacterial vaginosis. BVBLUE test method is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV), The BV BLUE Test contains a chromogenic substrate of sialidase enzyme, IBX-4041. BV Blue test is a commercially available test, it detects sialidase activity, an enzyme produced by BV-associated bacteria such as Gardnerella vaginalis, Bacteroides spp., Prevotella spp., and Mobiluncus spp. In the test procedure, a vaginal fluid sample is placed in the test vessel which contains a chromogenic substrate for sialidase. After incubation, a developer solution is added, and If the sample contained a high level of sialidase, a blue or green color is seen. Samples containing no sialidase, or low levels of this enzyme, will generate a yellow color in the reaction. The BV test has high specificity and sensitivity. The BVBlue test enables rapid detection of BV in a physician's office, and can thereby provide advantages over the Amsel methods and other methods requiring extensive laboratory testing. Advantage of BVBLUE Test Kit Compared to other diagnostic test methods for BV such as Amsel criteria, Nugent Gram-stain scoring system, Affirm�® Microbial Identification Test, BVBLUE Test Kit has following advantage: 1, BVBLUE Test is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV). 2, BVBLUE Test just take 10 minutes to 15 minutes to get the result. 3, High purity sialidase substrate with high specificity can reduce the occurrence of false positive. 4. Comparing with the gold standard, the coincidence rate is high, the relative sensitivity is 93%, and the specificity is 95%. 5. Easy to operate, do not need equipment. 6. The specimen does not need to pretreat.
Covid test kits FDA Approved I-Health , Flow Flex, Indicaid, Sienna, SD Biosensor as well as others not FDA but EU. Manufacturer and distributor of medical and industrial gloves (by box or bulk), masks, gowns, syringes etc. Medical gloves - Nitrile, Vinyl, latex. Industrial gloves - for automobile industry . Covid test kits Nano - POC I Health Flowflex DeepBlue Bosen
Real time PCR instrument. With 16-, 48-, or 96- wells. with 4-. 5-. or 6- channels.
Hello My name is Joe President of Blinq Wholesale supplier of Rapid Antigen Covid 19 test. We have 8m IHEALTH test available at our Los Angeles warehouse for $1.90 per test a box and it comes with the 6 month extension on the exp date till Jan 2023 We also have 10m Flowflex At $2.00 Per Box. All Units Are Here In The United States And Ready For Delivery. Price IS Negotiable as your quantity goes up. If you have any questions please email us
nasal or throat swab, 25 tests per box, it has CE certificate